Enrolling Pregnant Women: Issues in Clinical Research

Mary C. Blehar, Catherine Spong, Christine Grady, Sara F. Goldkind, Leyla Sahin, Janine A. Clayton

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Background: Despite the fact that many pregnant women are affected by a range of serious health conditions and take medications for these conditions, there is widespread reticence to include them in clinical intervention research. Hence, their clinical care is typically not informed by evidence derived from pregnant populations. Method: In October 2010, the National Institutes of Health Office of Research on Women's Health convened a workshop to address ethical, regulatory, and scientific issues raised by the enrollment of pregnant women in clinical research. This report summarizes three areas that emerged from that meeting as important next steps to be taken to promote ethically responsible and scientifically sound research during pregnancy. Findings: The three areas are: 1) Reclassify pregnant women from their current status in regulations as a " vulnerable" population to a scientifically " complex" population and change the presumption of exclusion to one of inclusion; 2) examine the institutional review boards' (IRB) gatekeeper role in interpreting regulations governing pregnancy research and identify steps to facilitate IRB approval of ethically informed pregnancy research; and 3) develop a pregnancy-focused research agenda that addresses pressing clinical needs, identifies opportunities to gather information from existing resources and studies, and encourages important new research areas. Conclusion: Research is needed to address the therapeutic needs of pregnant women and to study pregnancy as it may shed light on a pregnant woman's later health and the health of her child.

Original languageEnglish (US)
Pages (from-to)e39-e45
JournalWomen's Health Issues
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

women's issues
Pregnant Women
Research
pregnancy
Pregnancy
health
Research Ethics Committees
Women's Health
regulation
gatekeeper
National Institutes of Health (U.S.)
Vulnerable Populations
Population
medication
exclusion
inclusion
Education

ASJC Scopus subject areas

  • Health(social science)
  • Obstetrics and Gynecology
  • Public Health, Environmental and Occupational Health
  • Maternity and Midwifery

Cite this

Blehar, M. C., Spong, C., Grady, C., Goldkind, S. F., Sahin, L., & Clayton, J. A. (2013). Enrolling Pregnant Women: Issues in Clinical Research. Women's Health Issues, 23(1), e39-e45. https://doi.org/10.1016/j.whi.2012.10.003

Enrolling Pregnant Women : Issues in Clinical Research. / Blehar, Mary C.; Spong, Catherine; Grady, Christine; Goldkind, Sara F.; Sahin, Leyla; Clayton, Janine A.

In: Women's Health Issues, Vol. 23, No. 1, 01.01.2013, p. e39-e45.

Research output: Contribution to journalArticle

Blehar, MC, Spong, C, Grady, C, Goldkind, SF, Sahin, L & Clayton, JA 2013, 'Enrolling Pregnant Women: Issues in Clinical Research', Women's Health Issues, vol. 23, no. 1, pp. e39-e45. https://doi.org/10.1016/j.whi.2012.10.003
Blehar MC, Spong C, Grady C, Goldkind SF, Sahin L, Clayton JA. Enrolling Pregnant Women: Issues in Clinical Research. Women's Health Issues. 2013 Jan 1;23(1):e39-e45. https://doi.org/10.1016/j.whi.2012.10.003
Blehar, Mary C. ; Spong, Catherine ; Grady, Christine ; Goldkind, Sara F. ; Sahin, Leyla ; Clayton, Janine A. / Enrolling Pregnant Women : Issues in Clinical Research. In: Women's Health Issues. 2013 ; Vol. 23, No. 1. pp. e39-e45.
@article{eeddc357dbb34488b2c7b71687a22f22,
title = "Enrolling Pregnant Women: Issues in Clinical Research",
abstract = "Background: Despite the fact that many pregnant women are affected by a range of serious health conditions and take medications for these conditions, there is widespread reticence to include them in clinical intervention research. Hence, their clinical care is typically not informed by evidence derived from pregnant populations. Method: In October 2010, the National Institutes of Health Office of Research on Women's Health convened a workshop to address ethical, regulatory, and scientific issues raised by the enrollment of pregnant women in clinical research. This report summarizes three areas that emerged from that meeting as important next steps to be taken to promote ethically responsible and scientifically sound research during pregnancy. Findings: The three areas are: 1) Reclassify pregnant women from their current status in regulations as a {"} vulnerable{"} population to a scientifically {"} complex{"} population and change the presumption of exclusion to one of inclusion; 2) examine the institutional review boards' (IRB) gatekeeper role in interpreting regulations governing pregnancy research and identify steps to facilitate IRB approval of ethically informed pregnancy research; and 3) develop a pregnancy-focused research agenda that addresses pressing clinical needs, identifies opportunities to gather information from existing resources and studies, and encourages important new research areas. Conclusion: Research is needed to address the therapeutic needs of pregnant women and to study pregnancy as it may shed light on a pregnant woman's later health and the health of her child.",
author = "Blehar, {Mary C.} and Catherine Spong and Christine Grady and Goldkind, {Sara F.} and Leyla Sahin and Clayton, {Janine A.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.whi.2012.10.003",
language = "English (US)",
volume = "23",
pages = "e39--e45",
journal = "Women's Health Issues",
issn = "1049-3867",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Enrolling Pregnant Women

T2 - Issues in Clinical Research

AU - Blehar, Mary C.

AU - Spong, Catherine

AU - Grady, Christine

AU - Goldkind, Sara F.

AU - Sahin, Leyla

AU - Clayton, Janine A.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background: Despite the fact that many pregnant women are affected by a range of serious health conditions and take medications for these conditions, there is widespread reticence to include them in clinical intervention research. Hence, their clinical care is typically not informed by evidence derived from pregnant populations. Method: In October 2010, the National Institutes of Health Office of Research on Women's Health convened a workshop to address ethical, regulatory, and scientific issues raised by the enrollment of pregnant women in clinical research. This report summarizes three areas that emerged from that meeting as important next steps to be taken to promote ethically responsible and scientifically sound research during pregnancy. Findings: The three areas are: 1) Reclassify pregnant women from their current status in regulations as a " vulnerable" population to a scientifically " complex" population and change the presumption of exclusion to one of inclusion; 2) examine the institutional review boards' (IRB) gatekeeper role in interpreting regulations governing pregnancy research and identify steps to facilitate IRB approval of ethically informed pregnancy research; and 3) develop a pregnancy-focused research agenda that addresses pressing clinical needs, identifies opportunities to gather information from existing resources and studies, and encourages important new research areas. Conclusion: Research is needed to address the therapeutic needs of pregnant women and to study pregnancy as it may shed light on a pregnant woman's later health and the health of her child.

AB - Background: Despite the fact that many pregnant women are affected by a range of serious health conditions and take medications for these conditions, there is widespread reticence to include them in clinical intervention research. Hence, their clinical care is typically not informed by evidence derived from pregnant populations. Method: In October 2010, the National Institutes of Health Office of Research on Women's Health convened a workshop to address ethical, regulatory, and scientific issues raised by the enrollment of pregnant women in clinical research. This report summarizes three areas that emerged from that meeting as important next steps to be taken to promote ethically responsible and scientifically sound research during pregnancy. Findings: The three areas are: 1) Reclassify pregnant women from their current status in regulations as a " vulnerable" population to a scientifically " complex" population and change the presumption of exclusion to one of inclusion; 2) examine the institutional review boards' (IRB) gatekeeper role in interpreting regulations governing pregnancy research and identify steps to facilitate IRB approval of ethically informed pregnancy research; and 3) develop a pregnancy-focused research agenda that addresses pressing clinical needs, identifies opportunities to gather information from existing resources and studies, and encourages important new research areas. Conclusion: Research is needed to address the therapeutic needs of pregnant women and to study pregnancy as it may shed light on a pregnant woman's later health and the health of her child.

UR - http://www.scopus.com/inward/record.url?scp=84872225973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872225973&partnerID=8YFLogxK

U2 - 10.1016/j.whi.2012.10.003

DO - 10.1016/j.whi.2012.10.003

M3 - Article

C2 - 23312713

AN - SCOPUS:84872225973

VL - 23

SP - e39-e45

JO - Women's Health Issues

JF - Women's Health Issues

SN - 1049-3867

IS - 1

ER -